Skip to main content
logo
Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.4425
-0.0175 (-3.80%)
Oct 19, 2026, 12:37 PM EDT - Market open

Citius Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
-46.27-37.43-39.14-32.54-33.64-23.05
Depreciation & Amortization
0.130.210.210.190.180.16
Stock-Based Compensation
14.9710.8612.126.724.281.52
Other Operating Activities
-11.7-1.250.290.580.58-0.17
Change in Accounts Receivable
-0.69-----
Change in Inventory
-4.05-12.65-2.13---
Change in Accounts Payable
-2.068.7721.76-0.11-0.58
Change in Other Net Operating Assets
10.614.94-1.55-5.770.35-2.14
Operating Cash Flow
-34.87-26.55-28.2-29.06-28.36-24.25
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Capital Expenditures
------0.01
Sale (Purchase) of Intangibles
-12.75-5.75-5---40
Investing Cash Flow
-12.75-5.75-5---40.01

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Short-Term Debt Issued
-1.3----
Total Debt Issued
9.641.3----
Short-Term Debt Repaid
--0.3----0.17
Total Debt Repaid
-1-0.3----0.17
Net Debt Issued (Repaid)
8.641----0.17
Issuance of Common Stock
50.7932.313.815.03-127.71
Other Financing Activities
-0.89--3.83-1.2--7.07
Financing Cash Flow
58.5433.39.9713.83-120.47

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Cash Flow
10.921-23.23-15.23-28.3656.21

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Free Cash Flow
-34.87-26.55-28.2-29.06-28.36-24.26
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.60-2.40-4.19-4.80-4.85-5.58
Levered Free Cash Flow
-36.8-23.388.02-19.85-15.94-55.61
Unlevered Free Cash Flow
-36.55-23.218.02-19.85-15.94-55.61

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash Interest Paid
0.490.19---0.04
Change in Working Capital
3.821.05-1.69-4.010.24-2.72
SEC Filings: 10-K · 10-Q